Recalls / Active ingredient / Tolterodine Tartrate
Tolterodine Tartrate
1 FDA drug recall involving the active ingredient “Tolterodine Tartrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-03-04 | Class III | Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged | The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories |